Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic microorganisms – epithelial adhesion sites refers to the diverse array of molecular structures on the surface of host epithelial cells that serve as docking points for bacteria, viruses, and other pathogens. These sites typically include cell surface receptors such as Intercellular Adhesion Molecule-1 (ICAM-1) and Platelet-Activating Factor Receptor (PAFR), cell adhesion molecules like integrins and cadherins, and various glycans including sialic acid and heparan sulfate. Pathogens utilize specialized surface proteins, known as adhesins or attachment proteins, to recognize and bind to these specific host sites, which is a critical first step in colonization, tissue invasion, and the establishment of infection. Therapeutic strategies targeting these sites aim to prevent or treat infections by blocking the initial attachment phase. This can be achieved through competitive inhibitors like D-mannose for urinary tract infections, monoclonal antibodies that mask host receptors or pathogen adhesins, or probiotics that occupy these sites to exclude pathogens. Unlike traditional antibiotics, anti-adhesion therapies often exert less selective pressure for resistance and can be used as prophylactic or adjunctive treatments for various infectious diseases, particularly in the respiratory and gastrointestinal tracts.
Competitive inhibition of pathogen binding to host epithelial receptors, steric hindrance of the adhesion interface, and downregulation of host receptor expression to prevent colonization and invasion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic microorganisms – epithelial adhesion sites.